+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Benign Prostatic Hyperplasic Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Procedure Type, and End User, and Geography- Product Image
Benign Prostatic Hyperplasic Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Procedure Type, and End User, and Geography- Product Image
Sale

Benign Prostatic Hyperplasic Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Procedure Type, and End User, and Geography

  • PDF Icon

    Report

  • 190 Pages
  • July 2022
  • Region: Global
  • The Insight Partners
  • ID: 5646829
UP TO OFF until Jun 30th 2024
Description Jump to:
The global benign prostatic hyperplasic devices market is expected to US$ 2,078.78 million in 2021 to US$ 3,467.31 million by 2028; it is expected to grow with a CAGR of 7.6% from 2022 to 2028.

An increase in the prevalence of benign prostatic hyperplasia along with growing risk factors and a rise in investments, funds, and grants for research in BPH treatment boost the global benign prostatic hyperplasic devices market growth.

Benign prostatic hyperplasia (BPH) is a prostate enlargement caused by excessive cell growth in the prostate. BPH is a benign (non-cancerous) prostate condition. Non-cancerous conditions are not usually fatal and do not spread (metastasize) to other body parts. BPH doesn't raise the risk of prostate cancer; unless it manifests symptoms, BPH isn't considered a health issue. Almost all men will have some prostate growth by the age of 70. Getting older, having more belly fat (also known as abdominal obesity), and not getting enough exercise to raise the risk of developing BPH.

Players operating in the benign prostatic hyperplasic devices industry focus on investing high amounts in the development of advanced surgical technologies as alternatives to conventional techniques. Advanced devices enabled with new technologies help provide immediate relief and reduce morbidity.

  • In January 2022, ProVerum, a start-up supported by EIT Health, received US$ 31.22 million in Series A funding from Gilde Healthcare, Lightstone Ventures, and Atlantic Bridge. ProVerum, an Irish company, has developed ProVee, a cutting-edge treatment solution for men with symptomatic BPH. The company aims to market its innovative device in the US and Europe with the help of recent funding.
  • In June 2021, Zenflow, Inc., a medical device company developing a minimally invasive treatment for urinary obstruction caused by BPH or enlarged prostate, declared the completion of its Series B funding round with a total of US$ 24 million. The investment was led by Invus Opportunities and included participation from Medical Technology Venture Partners, F-Prime Capital, CloudStone Capital, Astia Angels, Golden Seeds, SV Tech Ventures, etc.
  • In June 2021, Procept Biorobotics raised US$ 85 million to commercialize the AquaBeam system as a global BPH treatment. With this product, the company intends to make an impact with its water-based robotic technology in the field of prostate surgery. The series G financing was led by Fidelity Management & Research Company, with additional backing from T. Rowe Price Associates, CPMG, Perceptive Advisors, Viking Global Investors, and Duquesne Family Office. - In July 2019, Medeon Biodesign, Inc, a publicly traded Taiwan medical device company, announced that it recently led and closed an investment in Prodeon. Prodeon is a Taiwan-based company offering a simple, office-based treatment option for patients who need quick relief from LUTS caused due to BPH. - In April 2018, ProVerum Medical closed a US$ 4.2 million seed investment, with Atlantic Bridge University Fund leading the investment round. With this investment, the company aims to commence its first human trials of its product for BPH treatment. This product includes a nitinol implant to dilate the prostatic urethra without altering the structure of the prostate anatomy. The nitinol implant can be manufactured to a small size to simplify the process of implantation through a 10-15-minute long minimally invasive surgery. - In February 2018, Zenflow, a medical device company based in San Francisco, California, announced a US$ 31.4 million Series A investment round for further advancements in its minimally invasive technique for treating BPH or an enlarged prostate.

Product-Based Insights

Based on the product, the benign prostatic hyperplasic devices market is segmented into resectoscopes, radiofrequency ablation devices, urology lasers, prostatic stents, and implants. The resectoscopes segment is likely to hold the largest market share in 2022. However, the urology lasers segment is anticipated to register the highest CAGR during the forecast period due to the high demand by physicians and the rising initiatives of market players in the launch and product expansion.

Procedure Type Insights

Based on procedure type, the benign prostatic hyperplasic devices market is segmented into transurethral microwave therapy, transurethral resection of the prostate, transurethral needle ablation of the prostate, laser surgery, urolift surgery, and others. In 2022, the transurethral resection of the prostate segment is likely to hold the market's largest share. Furthermore, the same segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to its visual, hands-on access to the prostate, ability to the immediate removal of excess tissue, the ability of transurethral resection of the prostate (TURP) to combine with other procedures.

End User-Based Insights

Based on end user, the benign prostatic hyperplasic devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment is likely to hold the largest share of the market. Moreover, the clinics segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to an increase in the number of clinics at a lower cost for treatment, easy accessibility, and flexibility with the short waiting time.

National Center for Biotechnology Information (NCBI), National Library of Medicine, Indiana University School of Medicine, Centers for Disease Control and Prevention (CDC), Canadian Risk Factor Atlas (CRFA), World Bank, Urology Foundation, International Diabetes Federation (IDF), National Statistics Institute (INE), National Medica Device Promotion Council, International Trade Administration, Department of Emergency Medicine are among the primary and secondary sources referred to while preparing the report on the benign prostatic hyperplasic devices market.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Benign Prostatic Hyperplasic Devices Market - By Product
1.3.2 Global Benign Prostatic Hyperplasic Devices Market - By Procedure Type
1.3.3 Global Benign Prostatic Hyperplasic Devices Market - By End User
1.3.4 Global Benign Prostatic Hyperplasic Devices Market - By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Benign Prostatic Hyperplasic Devices Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Benign Prostatic Hyperplasic Devices Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Benign Prostatic Hyperplasia along with Growing Risk Factors
5.1.2 Rise in Investments, Funds, and Grants for Research in BPH Treatment
5.2 Market Restraints
5.2.1 Low Awareness of Prostate Health Among Men
5.3 Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Product Approvals and Launches
5.5 Impact Analysis
6. Benign Prostatic Hyperplasic Devices Market - Global Analysis
6.1 Global Benign Prostatic Hyperplasic Devices Market Revenue Forecast and Analysis
6.2 Global Benign Prostatic Hyperplasic Devices Market, By Geography - Forecast and Analysis
6.3 Global Benign Prostatic Hyperplasic Devices Market - Market Potential Analysis, By Region
6.4 Company Analysis
6.4.1 Market Positioning of Key Players
6.4.2 Comparative Company Analysis
6.5 Growth Strategy Analysis
6.6 Performance of Key Players
6.6.1 Olympus Corporation
6.6.2 Butterfly Medical
7. Global Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028 - by Product
7.1 Benign Prostatic Hyperplasic Devices Market Revenue Share, by Product (2022 and 2028)
7.2 Resectoscopes
7.2.1 Overview
7.2.2 Resectoscopes: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
7.3 Urology Lasers
7.3.1 Overview
7.3.2 Urology Lasers: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Radiofrequency Ablation Devices
7.4.1 Overview
7.4.2 Radiofrequency Ablation Devices: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Prostatic Stents
7.5.1 Overview
7.5.2 Prostatic Stents: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Implants
7.6.1 Overview
7.6.2 Implants: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
8. Global Benign Prostatic Hyperplasic Devices Market Analysis and Forecast to 2028 - by Procedure Type
8.1 Benign Prostatic Hyperplasic Devices Market Revenue Share, by Procedure Type (2022 and 2028)
8.2 Transurethral Microwave Therapy
8.2.1 Overview
8.2.2 Transurethral Microwave Therapy: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
8.3 Transurethral Resection of the Prostate
8.3.1 Overview
8.3.2 Transurethral Resection of the Prostate: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Transurethral Needle Ablation of the Prostate
8.4.1 Overview
8.4.2 Transurethral Needle Ablation of the Prostate: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Laser Surgery
8.5.1 Overview
8.5.2 Laser Surgery: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
8.6 UroLift Surgery
8.6.1 Overview
8.6.2 UroLift Surgery: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
9. Global Benign Prostatic Hyperplasic Devices Market Analysis and Forecast to 2028 - by End User
9.1 Overview
9.2 Benign Prostatic Hyperplasic Devices Market Revenue Share, by End User (2022 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics Market Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
10. Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 - Geographical Analysis
10.1 North America: Benign Prostatic Hyperplasic Devices Market
10.1.1 Overview
10.1.2 North America: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Benign Prostatic Hyperplasic Devices Market, by Product, 2019-2028 (US$ Million)
10.1.4 North America: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019-2028 (US$ Million)
10.1.5 North America: Benign Prostatic Hyperplasic Devices Market, by End User, 2019-2028 (US$ Million)
10.1.6 North America: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
10.1.6.1 US: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Benign Prostatic Hyperplasic Devices Market, by Product, 2019-2028 (US$ Million)
10.1.6.1.4 US: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019-2028 (US$ Million)
10.1.6.1.5 US: Benign Prostatic Hyperplasic Devices Market, by End User, 2019-2028 (US$ Million)
10.1.6.2 Canada: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Benign Prostatic Hyperplasic Devices Market, by Product, 2019-2028 (US$ Million)
10.1.6.2.4 Canada: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019-2028 (US$ Million)
10.1.6.2.5 Canada: Benign Prostatic Hyperplasic Devices Market, by End User, 2019-2028 (US$ Million)
10.1.6.3 Mexico: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Benign Prostatic Hyperplasic Devices Market, by Product, 2019-2028 (US$ Million)
10.1.6.3.4 Mexico: Benign Prostatic Hyperplasic Devices Market, by Procedure Type, 2019-2028 (US$ Million)
10.1.6.3.5 Mexico: Benign Prostatic Hyperplasic Devices Market, by End User, 2019-2028 (US$ Million)
10.2 Europe: Benign Prostatic Hyperplasic Devices Market
10.2.1 Overview
10.2.2 Europe: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
10.2.4 Europe: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
10.2.5 Europe: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.2.6 Europe: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
10.2.6.1 UK: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 UK: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 UK: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.4 UK: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.5 UK: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2 Germany: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 Germany: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 Germany: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.4 Germany: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.5 Germany: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3 France: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 France: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 France: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.4 France: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.5 France: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4 Italy: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Italy: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.4 Italy: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.5 Italy: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5 Spain: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Spain: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.4 Spain: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.5 Spain: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6 Rest of Europe: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by Product- Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by Procedure Type - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.5 Rest of Europe: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.3 Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028
10.3.1 Overview
10.3.2 Asia Pacific Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.3.4 Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.3.5 Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6 Asia Pacific: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
10.3.6.1 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.3 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.3.6.1.4 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.3.6.1.5 China: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.2 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.3 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.3.6.2.4 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.3.6.2.5 Japan: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.3 India Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.3 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.3.6.3.4 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.3.6.3.5 India: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.4 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.3 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.3.6.4.4 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.3.6.4.5 South Korea: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.5 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.3 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.3.6.5.4 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.3.6.5.5 Australia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.6 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.4 Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028
10.4.1 Overview
10.4.2 Middle East & Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.4.5 Middle East & Africa: Metabolomics Market Revenue and Forecast to 2028, By End User (US$ Million)
10.4.6 Middle East & Africa: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
10.4.6.1 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Overview
10.4.6.1.2 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.3 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.4.6.1.4 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
10.4.6.1.5 Saudi Arabia: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By End User (US$ Million)
10.4.6.2 South Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 Overview
10.4.6.2.2 South Africa Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.3 South Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.4.6.2.4 South Africa: Metabolomics Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
10.4.6.2.5 South Africa: Metabolomics Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
10.4.6.3 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 Overview
10.4.6.3.2 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.3 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.4.6.3.4 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
10.4.6.3.5 UAE: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By End User (US$ Million)
10.4.6.4 Rest of Middle East and Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East and Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
10.4.6.4.5 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecast To 2028, By End User (US$ Million)
10.5 South And Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028
10.5.1 Overview
10.5.2 South and Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.5.3 South and Central America Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.5.4 South and Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Procedure Type (US$ Million)
10.5.5 South and Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By End User (US$ Million)
10.5.6 South and Central America: Benign Prostatic Hyperplasic Devices Market, by Country, 2022 & 2028 (%)
10.5.6.1 Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Overview
10.5.6.1.2 Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3 Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.5.6.1.4 Brazil: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
10.5.6.1.5 Brazil: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.5.6.2 Argentina Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Overview
10.5.6.2.2 Argentina Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3 Argentina: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.5.6.2.4 Argentina: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
10.5.6.2.5 Argentina: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
10.5.6.3 Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market- Revenue and Forecast to 2028 (USD Mn)
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market- Revenue and Forecast to 2028 (USD Mn)
10.5.6.3.3 Rest of South & Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast to 2028, By Product (US$ Million)
10.5.6.3.4 Rest of South & Central America: Benign Prostatic Hyperplasic Devices Market Revenue and Forecast To 2028, By Procedure Type (US$ Million)
10.5.6.3.5 Rest of South and Central America: Benign Prostatic Hyperplasic Devices Market, by End User - Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Benign Prostatic Hyperplasic Devices Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Benign Prostatic Hyperplasic Devices Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Benign Prostatic Hyperplasia Devices Market
12.3 Inorganic Growth Strategies
12.4 Organic Growth Strategies
13. Company Profiles
13.1 KARL STORZ SE & Co. KG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Richard Wolf GmbH
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Olympus Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Urologix, LLC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Boston Scientific Corporation
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Butterfly
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Teleflex Incorporated
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 OmniGuide Holdings, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Convergent Laser Technologies
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ProArc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms for Benign Prostatic Hyperplasia Devices Market

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • KARL STORZ SE & Co. KG
  • Richard Wolf GmbH
  • Olympus Corporation
  • Urologix, LLC.
  • Boston Scientific Corporation
  • Butterfly
  • TELEFLEX Incorporated
  • OmniGuide Holdings, Inc.
  • Convergent Laser Technologies
  • ProArc
  • Olympus Corporation

Table Information

Report AttributeDetails
No. of Pages190
PublishedJuly 2022
Forecast Period2022 - 2028
Estimated Market Value ( USD ) in 2022 $ 2078.78 million
Forecasted Market Value ( USD ) by 2028 $ 3467.31 million
Compound Annual Growth Rate7.6%
Regions CoveredGlobal

Related Topics

Related Reports

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024 - Product Image

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Benign Prostatic Hyperplasia Devices - Global Strategic Business Report - Product Image

Benign Prostatic Hyperplasia Devices - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Benign Prostatic Hyperplasia Device Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Benign Prostatic Hyperplasia Device Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 98 Pages
  • Global
From
Nephrology And Urology Devices - Global Strategic Business Report - Product Image

Nephrology And Urology Devices - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Global Urology Medical Lasers Market by Laser Type (Diode Laser System, Holmium Laser System, Thulium Laser System), Application (Benign Prostatic Hyperplasia, Non-Muscle-Invasive Bladder Cancer, Urolithiasis) - Forecast 2024-2030 - Product Image

Global Urology Medical Lasers Market by Laser Type (Diode Laser System, Holmium Laser System, Thulium Laser System), Application (Benign Prostatic Hyperplasia, Non-Muscle-Invasive Bladder Cancer, Urolithiasis) - Forecast 2024-2030

  • Report
  • 183 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.